"The sequencing of both P. falciparum and its insect vector heralds a new era in the fight against malaria. When joined with information we have about the human genome, a much fuller understanding of this disease and its transmission is now possible," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID). "NIAID is proud to have contributed to this extraordinary scientific achievement, which will speed efforts to investigate and develop control strategies for this devastating disease."
The medical, social and economic ravages of malaria are most keenly felt in Africa, where 90 percent of the up to 2.7 million annual deaths worldwide from the disease occur. Most victims are children less than 5 years old; on average, a child succumbs to malaria every 30 seconds. Malaria causes cycles of fever and chills that accompany cyclical destruction of parasite-infected red blood cells. Debilitating and life-threatening complications of malaria include severe anemia, cerebral malaria, and respiratory distress. The disease is caused by single-celled parasites of the genus Plasmodium, which are transmitted from person to person through the bite of an infected mosquito. The menace posed by malaria is increasing with the spread of drug-resistant parasite strains and insecticide-resistant mosquitoes. No vaccine exists.
The sequencing of P. falciparum resulted from an international collaboration established in 1996. Besides NIAID, consortium support came from the Wellcome Trust, the Burro
Contact: Anne A. Oplinger
NIH/National Institute of Allergy and Infectious Diseases